Cargando…

Acute Kidney Injury in the Outpatient Setting: Developing and Validating a Risk Prediction Model

RATIONALE & OBJECTIVE: Risk factors for acute kidney injury (AKI) in the hospital have been well studied. Yet, risk factors for identifying high-risk patients for AKI occurring and managed in the outpatient setting are unknown and may differ. STUDY DESIGN: Predictive model development and extern...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Daniel, Reule, Scott, Vock, David, Drawz, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767133/
https://www.ncbi.nlm.nih.gov/pubmed/35072041
http://dx.doi.org/10.1016/j.xkme.2021.08.011
Descripción
Sumario:RATIONALE & OBJECTIVE: Risk factors for acute kidney injury (AKI) in the hospital have been well studied. Yet, risk factors for identifying high-risk patients for AKI occurring and managed in the outpatient setting are unknown and may differ. STUDY DESIGN: Predictive model development and external validation using observational electronic health record data. SETTING & PARTICIPANTS: Patients aged 18-90 years with recurrent primary care encounters, known baseline serum creatinine, and creatinine measured during an 18-month outcome period without established advanced kidney disease. NEW PREDICTORS & ESTABLISHED PREDICTORS: Established predictors for inpatient AKI were considered. Potential new predictors were hospitalization history, smoking, serum potassium levels, and prior outpatient AKI. OUTCOMES: A ≥50% increase in the creatinine level above a moving baseline of the recent measurement(s) without a hospital admission within 7 days defined outpatient AKI. ANALYTICAL APPROACH: Logistic regression with bootstrap sampling for backward stepwise covariate elimination was used. The model was then transformed into 2 binary tests: one identifying high-risk patients for research and another identifying patients for additional clinical monitoring or intervention. RESULTS: Outpatient AKI was observed in 4,611 (3.0%) and 115,744 (2.4%) patients in the development and validation cohorts, respectively. The model, with 18 variables and 3 interaction terms, produced C statistics of 0.717 (95% CI, 0.710-0.725) and 0.722 (95% CI, 0.720-0.723) in the development and validation cohorts, respectively. The research test, identifying the 5.2% most at-risk patients in the validation cohort, had a sensitivity of 0.210 (95% CI, 0.208-0.213) and specificity of 0.952 (95% CI, 0.951-0.952). The clinical test, identifying the 20% most at-risk patients, had a sensitivity of 0.494 (95% CI, 0.491-0.497) and specificity of 0.806 (95% CI, 0.806-0.807). LIMITATIONS: Only surviving patients with measured creatinine levels during a baseline period and outcome period were included. CONCLUSIONS: The outpatient AKI risk prediction model performed well in both the development and validation cohorts in both continuous and binary forms.